Empowering pharmaceutical innovators with advanced delivery solutions.

For over 2 decades, we’ve enabled pharma innovators to develop, scale, and launch high-quality solid dosage forms across global markets. With a strong scientific backbone and a commitment to excellence, we continuously strive to transform complex formulations into commercial success.

Our Journey

2004

Our journey began with a single U.S. pharmacy founded by first-generation pharmacist Mani Patel, built on a strong commitment to patient care and accessible healthcare.

2009

The pharmacy business rapidly expanded into a network of over 80 locations across the United States, providing deep insight into patient needs and pharmaceutical demand.

2012

Expanding beyond retail, the group launched a pharmaceutical distribution company, now servicing 42 U.S. states with scalable, nationwide delivery.

2016

To support vertical integration, the group established an in-house Nutra manufacturing facility in Windsor, Ontario. Operational for over 15 years, it is a leading nutraceutical and natural health products manufacturer.

2024

The group acquired and rebranded a Health Canada– and U.S. FDA-licensed CDMO as Medicap Laboratories, located in Etobicoke, GTA, Canada, specializing in contract research and manufacturing.

2025

This milestone completed our end-to-end pharmaceutical value chain, spanning development, manufacturing, distribution, and retail—delivering science-driven solutions with speed, flexibility, and full lifecycle control.

Our Facility

Medicap’s 70,000+ sq. ft. GMP-compliant site offers a modern, scalable platform for oral solid dosage development which supports projects from early-stage specialty molecule formulation through to commercial production. The facility integrates advanced research labs, analytical suites, and validated manufacturing cleanrooms, enabling fast, compliant, and high-quality product delivery for domestic and global markets.

With over 10 proprietary patents and an expanding portfolio of differentiated release technologies, the group continues to invest in innovation, regulatory excellence, and scientific capability ensuring that every part of the supply chain works in harmony to deliver value for partners and better outcomes for patients.

By capturing every stage of the pharmaceutical lifecycle from retail and distribution to manufacturing and R&D we are building a fully integrated ecosystem designed to deliver speed, flexibility, and strategic advantage to our clients worldwide.

Our Team

Our Team

At the heart of our leadership philosophy is a belief in transparency, accountability, and science-led execution. Each engagement is personally overseen by leadership to ensure alignment, responsiveness, and strategic continuity. We don’t just deliver we collaborate, adapt, and evolve with our partners.

Medicap is led by a seasoned team of pharmaceutical scientists, regulatory strategists, and industry executives with deep roots in product development and commercialization. Our leadership brings decades of experience managing end-to-end CDMO operations from early-phase research and regulatory engagement to global product launches.

Why Choose Us ?

We offer the best of both worlds: the operational excellence of a mature CDMO and the responsiveness of a boutique firm.

Our value lies not just in what we do, but in how we do it with scientific precision, flexible engagement models, and a relentless commitment to our clients’ success.

We specialize in complex oral delivery systems, with proprietary technologies like Hypermatrix™, PODRAS™, and nPODDDS™ all engineered for controlled, biphasic, or abuse-deterrent drug release. These technologies allow our clients to differentiate their products, protect IP, and expand market access.

We navigate regulatory complexity with confidence, thanks to years of experience submitting and supporting ANDAs, NDAs, and global filings.

Learn more about our technologies

Collaborate with us

We actively work with pharmaceutical companies, biotech startups, research institutions, and technology developers to bring novel drug products to life. Our collaboration models range from joint development and co-investment programs to strategic supply and technology licensing partnerships. By aligning with organizations that share our scientific vision and commitment to patient impact, we create win-win opportunities that accelerate timelines and maximize therapeutic potential.

Whether you’re looking to outsource development, scale manufacturing, or co-develop a proprietary platform, Medicap brings the infrastructure, talent, and regulatory strength to move your project forward.

Connect with our Business Development team